|
QuintilesIMS Real-World Insights Bibliography
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Survey on appropriateness of use of nimesulide in nine European countries |
| Author(s): Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. |
| Affiliations(s): 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
2Cegedim Strategic Data Medical Research Srl, Milan, Italy. |
| Publication(s): Drug, Healthcare and Patient Safety 2015:7 51-55 |
| Document Type(s): Article |
| Countries: Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia |
C:
Y: |
Pain
2015 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Slovakia |
| Author(s): Troelsgaard A1, Pitcher A2, Binder R3, Stetka R4, Ondrusova M5, Lovato E2, Hemels M1 |
| Affiliations(s): Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen, Bratislava, Slovak Republic, 4Pharm-In, Ltd, Bratislava, Slovak Republic, 5Pharm-In Ltd, Bratislava, Slovak Republic |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Slovakia |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Economic evaluation |
|
|
| |
| |
| Prevention of stroke in patients with Atrial Fibrillation: Cost-Utility Analysis of Rivaroxaban versus Warfarin in Slovakia |
| Author(s): Psenkova M1, Lukac M2, Mackovicova S3, Stachova M2, Bielik J4, Pietsch GA5, Asukai Y6, Lloyd A6, Evers T7 |
| Affiliations(s): 1Pharm-In, Bratislava, Slovak Republic, 2Bayer, Bratislava, Slovak Republic, 3Pharm-In, spol. s r.o., Bratislava, Slovak Republic, 4Trencin University, Trencin, Slovak Republic, 5Bayer Schering Pharma AG, Wupertal, GA, Germany, 6IMS Health, London, UK, 7Bayer Schering Pharma AG, Wuppertal, Germany |
| Publication(s): ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
| Document Type(s): Poster |
| Countries: Slovakia |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2012 |
|
L:
A: |
English
Cost utility |
|
|
| |
| |
| Cost-utility analysis of Rivaroxaban compared with Enoxaparin in prevention of venous thromboembolism after total hip replacement in Slovakia |
| Author(s): Pereira R1, Diamantopoulos A2, Bielik J3, Lees M4, Tomek D5, Lukac M6
|
| Affiliations(s): 1IMS Health, Barcelona, Spain, 2IMS Health HEOR, London, UK, 3University of A.Dubcek in Trencin, Bratislava, Slovak Republic, 4Bayer plc, Uxbridge, UK, 5Slovak Society for Pharmacoeconomics, Bratislava, Slovak Republic, 6Faculty of Public Health at Slovak Medical University, Bratislava, Slovak Republic |
| Publication(s): ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA
|
| Document Type(s): Poster |
| Countries: Slovakia |
| Click here for the abstract |
C:
Y: |
Vascular disease
2010 |
|
L:
A: |
English
|
|
|
| |
| |
|
|
|
